Posted by 
FDA has approved Sinuva (mometasone furoate) Sinus Implant, a new in-office treatment option for recurrent nasal polyps. Sinus Implant, a new targeted approach to treating recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery.
Sinuva can be used during a routine physician office visit, Sinuva expands into the sinus cavity and delivers an anti-inflammatory steroid directly to the site of polyp disease for 90 days.
Sinuva represents a much-needed breakthrough for the many nasal polyp sufferers who are seeking an effective treatment. Nasal polyps are inflammatory growths along the lining of nasal passages or sinuses that can cause nasal congestion, infections and loss of sense of smell.